Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis Meeting Abstract
| Authors: | George, D. J.; Martini, J. F.; Staehler, M. D.; Chang, Y. H.; Breza, J.; Patard, J. J.; Motzer, R. J.; Magheli, A.; Carteni, G.; Donskov, F.; Escudier, B.; Li, S.; Casey, M.; Valota, O.; Laguerre, B.; Pantuck, A. J.; Pandha, H. S.; Patel, A.; Lechuga, M.; Ravaud, A. |
| Abstract Title: | Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500569 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.576 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 576 -- Source: Wos |
